5,837 followers
New Research: A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19 https://t.co/og8GyLdpVN #pharmacology
New Research: A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19 https://t.co/og8GyLdpVN #pharmacology